vs

Side-by-side financial comparison of FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $44.3M, roughly 1.7× FIRST BUSINESS FINANCIAL SERVICES, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 8.5%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.0%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

FBIZ vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.7× larger
PBYI
$75.5M
$44.3M
FBIZ
Growing faster (revenue YoY)
PBYI
PBYI
+19.3% gap
PBYI
27.7%
8.5%
FBIZ
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
8.0%
FBIZ

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FBIZ
FBIZ
PBYI
PBYI
Revenue
$44.3M
$75.5M
Net Profit
$12.2M
Gross Margin
69.3%
Operating Margin
22.7%
Net Margin
27.5%
Revenue YoY
8.5%
27.7%
Net Profit YoY
9.2%
EPS (diluted)
$1.44
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIZ
FBIZ
PBYI
PBYI
Q1 26
$44.3M
Q4 25
$42.2M
$75.5M
Q3 25
$44.5M
$54.5M
Q2 25
$41.0M
$52.4M
Q1 25
$40.8M
$46.0M
Q4 24
$41.2M
$59.1M
Q3 24
$38.1M
$80.5M
Q2 24
$38.0M
$47.1M
Net Profit
FBIZ
FBIZ
PBYI
PBYI
Q1 26
$12.2M
Q4 25
$13.3M
Q3 25
$14.4M
$8.8M
Q2 25
$11.4M
$5.9M
Q1 25
$11.2M
$3.0M
Q4 24
$14.4M
Q3 24
$10.5M
$20.3M
Q2 24
$10.5M
$-4.5M
Gross Margin
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Operating Margin
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
38.5%
22.7%
Q3 25
39.0%
17.6%
Q2 25
32.6%
12.7%
Q1 25
33.0%
8.7%
Q4 24
37.2%
22.6%
Q3 24
33.8%
27.4%
Q2 24
32.6%
-4.6%
Net Margin
FBIZ
FBIZ
PBYI
PBYI
Q1 26
27.5%
Q4 25
31.6%
Q3 25
32.3%
16.2%
Q2 25
27.8%
11.2%
Q1 25
27.4%
6.5%
Q4 24
35.0%
Q3 24
27.6%
25.2%
Q2 24
27.5%
-9.6%
EPS (diluted)
FBIZ
FBIZ
PBYI
PBYI
Q1 26
$1.44
Q4 25
$1.57
$0.26
Q3 25
$1.70
$0.17
Q2 25
$1.35
$0.12
Q1 25
$1.32
$0.06
Q4 24
$1.69
$0.40
Q3 24
$1.24
$0.41
Q2 24
$1.23
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIZ
FBIZ
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$265.8M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
Total Assets
$4.3B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIZ
FBIZ
PBYI
PBYI
Q1 26
$265.8M
Q4 25
$39.5M
$97.5M
Q3 25
$44.3M
$94.4M
Q2 25
$123.2M
$96.0M
Q1 25
$170.6M
$93.2M
Q4 24
$157.7M
$101.0M
Q3 24
$132.0M
$96.7M
Q2 24
$81.1M
$96.8M
Total Debt
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Stockholders' Equity
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
$371.6M
$130.3M
Q3 25
$358.3M
$115.3M
Q2 25
$344.8M
$104.7M
Q1 25
$336.1M
$97.1M
Q4 24
$328.6M
$92.1M
Q3 24
$312.0M
$71.1M
Q2 24
$305.2M
$48.5M
Total Assets
FBIZ
FBIZ
PBYI
PBYI
Q1 26
$4.3B
Q4 25
$4.1B
$216.3M
Q3 25
$4.0B
$202.9M
Q2 25
$4.0B
$194.9M
Q1 25
$3.9B
$196.2M
Q4 24
$3.9B
$213.3M
Q3 24
$3.7B
$220.7M
Q2 24
$3.9B
$205.0M
Debt / Equity
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIZ
FBIZ
PBYI
PBYI
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
$61.7M
$14.4M
Q3 25
$18.4M
$9.7M
Q2 25
$15.8M
$14.1M
Q1 25
$11.3M
$3.6M
Q4 24
$57.5M
$15.6M
Q3 24
$13.8M
$11.0M
Q2 24
$13.1M
$1.0M
Free Cash Flow
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
$61.1M
$14.4M
Q3 25
$18.3M
$9.7M
Q2 25
$15.5M
$14.1M
Q1 25
$11.2M
$3.6M
Q4 24
$57.3M
$15.6M
Q3 24
$13.2M
$11.0M
Q2 24
$12.7M
$1.0M
FCF Margin
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
144.7%
19.1%
Q3 25
41.0%
17.7%
Q2 25
37.8%
26.8%
Q1 25
27.5%
7.7%
Q4 24
139.2%
26.4%
Q3 24
34.6%
13.7%
Q2 24
33.3%
2.1%
Capex Intensity
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
1.4%
0.0%
Q3 25
0.3%
0.0%
Q2 25
0.8%
0.0%
Q1 25
0.2%
0.1%
Q4 24
0.5%
0.0%
Q3 24
1.6%
0.0%
Q2 24
1.1%
0.0%
Cash Conversion
FBIZ
FBIZ
PBYI
PBYI
Q1 26
Q4 25
4.63×
Q3 25
1.28×
1.10×
Q2 25
1.39×
2.41×
Q1 25
1.01×
1.21×
Q4 24
3.99×
Q3 24
1.31×
0.54×
Q2 24
1.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons